Xtant Medical announced FDA 510(k) clearance to market the Xsert™ Lumbar Expandable Interbody System, including an indication to be packed with autograft or allogrant bone, such as Xtant’s 3Demin and OsteoSponge.
The Xsert all-titanium device expands in situ and features nanotextured endplate surfaces to encourage osteointegration.
Initial product launch will commence in mid-2017.
Sources: Xtant Medical Holdings, Inc.; ORTHOWORLD Inc.
Xtant Medical announced FDA 510(k) clearance to market the Xsert™ Lumbar Expandable Interbody System, including an indication to be packed with autograft or allogrant bone, such as Xtant's 3Demin and OsteoSponge.
The Xsert all-titanium device expands in situ and features nanotextured endplate surfaces to encourage...
Xtant Medical announced FDA 510(k) clearance to market the Xsert™ Lumbar Expandable Interbody System, including an indication to be packed with autograft or allogrant bone, such as Xtant’s 3Demin and OsteoSponge.
The Xsert all-titanium device expands in situ and features nanotextured endplate surfaces to encourage osteointegration.
Initial product launch will commence in mid-2017.
Sources: Xtant Medical Holdings, Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.